A Phase II Study of Paclitaxel in Advanced Bronchioloalveolar Carcinoma (EORTC Trial 08956)

Lung Cancer - Netherlands
doi 10.1016/j.lungcan.2005.05.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma With Bronchioloalveolar Carcinoma Subtype

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2009English

Thymostimulin in Advanced Hepatocellular Carcinoma: A Phase II Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

Phase II Trial of Fenretinide in Advanced Renal Carcinoma

Investigational New Drugs
OncologyPharmacology
2005English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research
MedicineCancer ResearchOncology
2020English

EO9 Phase II Study in Advanced Breast, Gastric, Pancreatic and Colorectal Carcinoma by the EORTC Early Clinical Studies Group

European Journal of Cancer
Cancer ResearchOncology
1996English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

Phase II Trial of Nab-Paclitaxel in the Treatment of Recurrent or Persistent Advanced Cervix Cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology
GynecologyOncologyObstetrics
2012English

A Phase II Study of Cixutumumab (IMC-A12, NSC742460) in Advanced Hepatocellular Carcinoma

Journal of Hepatology
Hepatology
2014English

A Phase II Trial of Gemcitabine Plus Carboplatin in Advanced Transitional Cell Carcinoma of the Urothelium

BMC Cancer
Cancer ResearchOncologyGenetics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy